(1 - 7 von 9
)
TNGX.O - | Stock Price & Latest NewsReuters
www.reuters.com
Reid M. Huber: Independent Director. Malte Peters: Independent Director. Mace Rothenberg: Independent Director. Financials. Income Statement. Annual
Incyte and Merus N.V. Announce Global Strategic Research...
www.finanznachrichten.de
Collaboration designed to leverage Merus' Biclonics bispecific antibody technology to expand Incyte's discovery capabilities and large-molecule portfolio...
Insider TransactionsPhiladelphia Inquirer
www.inquirer.com
— Reid M. Huber. , officer, sold 11,739 shares at $ on Jan. 9, and now directly holds 52,185 shares.
文献高级检索结果x-mol.com
newsletter.x-mol.com
Reid M Huber,Kathleen Murphy,Bowman Miao,John R Link,Mark R Cunningham,Mark J Rupar,Paul L Gunyuzlu,Thomas F Haws,Altaf Kassam,Francoise Powell,Gregory F ...
Calithera and Incyte Agree on $53M Up Front Deal for Clinical-Stage...
www.genengnews.com
Incyte retains rights to CB for hematology and oncology applications
Incyte and Calithera Biosciences Announce Global
www.globenewswire.com
Incyte gains worldwide rights to CB for hematology and oncology indications Calithera to receive a $45 million up-front payment and an $8 million...
VUMC and Incyte Corp. form new scientific alliance | VUMC Reporter...
news.vumc.org
Vanderbilt University Medical Center investigators have joined forces with scientists at Incyte Corp. to explore new therapies for the treatment of various...
sortiert nach Relevanz / Datum